DZ2770A1 - Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4. - Google Patents

Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4.

Info

Publication number
DZ2770A1
DZ2770A1 DZ990070A DZ990070A DZ2770A1 DZ 2770 A1 DZ2770 A1 DZ 2770A1 DZ 990070 A DZ990070 A DZ 990070A DZ 990070 A DZ990070 A DZ 990070A DZ 2770 A1 DZ2770 A1 DZ 2770A1
Authority
DZ
Algeria
Prior art keywords
glyoxamides
indol
substituted
preparation
glyoxamides substituted
Prior art date
Application number
DZ990070A
Other languages
English (en)
French (fr)
Inventor
Benjamin Alan Anderson
Nancy Kay Harn
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DZ2770A1 publication Critical patent/DZ2770A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DZ990070A 1998-04-17 1999-04-14 Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4. DZ2770A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8211098P 1998-04-17 1998-04-17

Publications (1)

Publication Number Publication Date
DZ2770A1 true DZ2770A1 (fr) 2003-12-01

Family

ID=22169126

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990070A DZ2770A1 (fr) 1998-04-17 1999-04-14 Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4.

Country Status (27)

Country Link
US (1) US6265591B1 (zh)
EP (1) EP1071663A4 (zh)
JP (1) JP2002512225A (zh)
KR (1) KR20010042741A (zh)
CN (1) CN1305459A (zh)
AR (1) AR015767A1 (zh)
AU (1) AU750368B2 (zh)
BR (1) BR9909697A (zh)
CA (1) CA2326515A1 (zh)
CO (1) CO5080803A1 (zh)
DZ (1) DZ2770A1 (zh)
EA (1) EA003582B1 (zh)
EG (1) EG22139A (zh)
HK (1) HK1039120A1 (zh)
HR (1) HRP20000685A2 (zh)
HU (1) HUP0101344A3 (zh)
ID (1) ID26021A (zh)
IL (1) IL138827A0 (zh)
NO (1) NO20005148L (zh)
NZ (1) NZ507175A (zh)
PE (1) PE20000430A1 (zh)
PL (1) PL343487A1 (zh)
SK (1) SK15372000A3 (zh)
SV (1) SV1999000043A (zh)
TR (1) TR200002999T2 (zh)
WO (1) WO1999054300A1 (zh)
ZA (1) ZA200005294B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407261B1 (en) 1998-04-17 2002-06-18 Eli Lilly And Company Process for preparing 4-hdyroxy indole, indazole and carbazole compounds
EP1071661A4 (en) * 1998-04-17 2001-08-22 Lilly Co Eli METHOD FOR PRODUCING 4-HYDROXYINDOL, INDAZOL AND CARBAZOL COMPOUNDS
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
US20030225149A1 (en) * 2002-04-30 2003-12-04 Blazecka Peter G. Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
EP3563842A1 (en) 2009-04-29 2019-11-06 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
AR088377A1 (es) 2011-10-20 2014-05-28 Siena Biotech Spa Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2179088T3 (es) 1994-04-01 2003-01-16 Lilly Co Eli Inhibidores de flsa2 1h-indol-3-glioxilamida.
EP1071661A4 (en) * 1998-04-17 2001-08-22 Lilly Co Eli METHOD FOR PRODUCING 4-HYDROXYINDOL, INDAZOL AND CARBAZOL COMPOUNDS

Also Published As

Publication number Publication date
EP1071663A4 (en) 2002-06-19
NO20005148L (no) 2000-11-09
SV1999000043A (es) 2000-05-02
EP1071663A1 (en) 2001-01-31
EA003582B1 (ru) 2003-06-26
SK15372000A3 (sk) 2001-08-06
HRP20000685A2 (en) 2001-10-31
BR9909697A (pt) 2000-12-19
HUP0101344A3 (en) 2002-12-28
EG22139A (en) 2002-08-30
PE20000430A1 (es) 2000-05-24
JP2002512225A (ja) 2002-04-23
HUP0101344A2 (hu) 2001-09-28
IL138827A0 (en) 2001-10-31
TR200002999T2 (tr) 2001-01-22
ZA200005294B (en) 2001-10-01
NZ507175A (en) 2002-12-20
CA2326515A1 (en) 1999-10-28
EA200001076A1 (ru) 2001-04-23
AR015767A1 (es) 2001-05-16
AU3564899A (en) 1999-11-08
WO1999054300A1 (en) 1999-10-28
ID26021A (id) 2000-11-16
PL343487A1 (en) 2001-08-27
US6265591B1 (en) 2001-07-24
AU750368B2 (en) 2002-07-18
NO20005148D0 (no) 2000-10-13
HK1039120A1 (zh) 2002-04-12
CO5080803A1 (es) 2001-09-25
KR20010042741A (ko) 2001-05-25
CN1305459A (zh) 2001-07-25

Similar Documents

Publication Publication Date Title
DZ3079A1 (fr) Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé.
TR199600792A2 (tr) Dihaloazolopirimidinlerin hazirlanmasina yönelik proses.
MA23395A1 (fr) Procede de preparation de nouvelles formulations
NO981800L (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
MA24182A1 (fr) Procede pour la preparation de 2,4-diaminopyrimidines substituees
DZ1946A1 (fr) Procédé pour la préparation de supports.
FR2818979B1 (fr) Procede de preparation d'imidaclopride
FR2764883B1 (fr) Procede de fabrication d'hydrofluoroalcanes
FR2721598B1 (fr) Procédé de préparation de catalyseurs d'ammoxydation.
FR2744648B1 (fr) Procede de preparation d'agents tensioactifs
FR2708266B1 (fr) Procédé de préparation d'alcanesulfonamides.
DZ2418A1 (fr) Procédé de préparation d'éprosartan
DZ2770A1 (fr) Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4.
FR2715656B1 (fr) Procédé de préparation d'anhydride citraconique.
FI961827A0 (fi) Menetelmä 1,3-diolien monoesterien valmistamiseksi
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
NO985535L (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
FR2728268B1 (fr) Procede de preparation de gamma-cyclodextrine
FR2719580B1 (fr) Procédé de préparation d'octadiénols.
DZ2771A1 (fr) Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4.
FR2700538B1 (fr) Procédé de préparation de 2-méthyl-3-aminobenzotrifluorure.
FR2750998B1 (fr) Procede de preparation de k-carraghenase
IL141947A0 (en) Process for the preparation of 4,4'-dihalogen-o-hydroxydiphenyl compounds
NO20005743D0 (no) Fremgangsmåte til fremstilling av 4,5-epoksymorfinan-6- oksyglukoronider
FR2728566B1 (fr) Procede de preparation de pentene-nitriles